Skip to content

Mixed Phenotype Acute Leukemia T Myeloid Not Otherwise Specified C2826055

Published: July 22, 2026Updated: August 20, 2026

A rare blood cancer where leukemic cells show both T-cell and myeloid characteristics, affecting children and adults. Treated with intensive chemotherapy and stem cell transplant, with serious prognosis.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Severe headache

Fatigue

(hematologic)

Mucosal bleeding

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Multi-agent chemotherapy regimen

Intensive combination chemotherapy based on acute lymphoblastic leukemia (ALL) protocols, typically including vincristine, corticosteroids, and cyclophosphamide to induce remission in this aggressive leukemia.

medication
2

Outpatient procedure with monitoring

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Allogeneic hematopoietic stem cell transplantation

After achieving remission with chemotherapy, consolidation with stem cell transplant from a matched donor provides the best chance for durable remission in this high-risk leukemia.

procedure

Additional treatment options

Targeted therapy with tyrosine kinase inhibitors

For cases with specific genetic markers, targeted agents may be added to standard chemotherapy to improve response rates and reduce relapse risk.

medication

Intensive laboratory and imaging surveillance

Frequent complete blood counts, bone marrow biopsies, and imaging studies to assess treatment response, detect minimal residual disease, and identify complications early.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Mixed Phenotype Acute Leukemia T Myeloid Not Otherwise Specified C2826055?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Alpermann AM, Schnittger S, Kern W, et al. Diagnosis and Treatment of Mixed Phenotype Acute Leukemia: ELN Recommendations. Blood. 2021.

guideline2021
2

Wolach O, Stone RM. Mixed Phenotype Acute Leukemia: Current Concepts and Future Directions. Leukemia. 2020.

review2020
3

Shimony S, Zahran D, Horowitz NA, et al. Treatment Outcomes of Mixed Phenotype Acute Leukemia: A Retrospective Analysis. Haematologica. 2022.

clinical_trial2022
4

Mrózek K, Carroll AJ, Raimondi SC, et al. Immunophenotypic Classification and Clinical Features of Mixed Phenotype Acute Leukemia. J Clin Oncol. 2019.

review2019

Medication Comparisons

Compare medications used to treat Mixed Phenotype Acute Leukemia T Myeloid Not Otherwise Specified C2826055. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy